Central nervous system (CNS) disorders are a broad category of neurological diseases, many of which have few or no therapeutic treatment options. Axonis, our most recent investment, has a novel approach for developing neuro-restorative, neuro-protective, and neuro-regenerative therapies.
-min.jpeg)